Pulse Biosciences, Inc. released an updated investor presentation on January 14, 2025, showcasing advancements in its product development programs for devices like the nPulse Vybrance Percutaneous Electrode, expected to facilitate future investor presentations. This event is significant for the company and is viewed positively by investors.